Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Monika J. Sirch
Multidomain Targeting of BCR-Abl by Disruption of Oligomerization and Tyrosine Kinase Inhibition: Toward Eradication of CML
Molecular Pharmaceutics
Drug Discovery
Molecular Medicine
Pharmaceutical Science
Related publications
Inhibition of the BCR-Abl Tyrosine Kinase as a Therapeutic Strategy for CML
Oncogene
Cancer Research
Genetics
Molecular Biology
BCR-ABL Tyrosine Kinase
Science-Business eXchange
Inhibition of BCR Serine Kinase by Tyrosine Phosphorylation.
Molecular and Cellular Biology
Cell Biology
Molecular Biology
Evolution of BCR/ABL Gene Mutation in CML Is Time Dependent and Dependent on the Pressure Exerted by Tyrosine Kinase Inhibitor
PLoS ONE
Multidisciplinary
Oligomerization of the ABL Tyrosine Kinase by the Ets Protein TEL in Human Leukemia.
Molecular and Cellular Biology
Cell Biology
Molecular Biology
Oligomerization Inhibition, Combined With Allosteric Inhibition, Abrogates the Transformation Potential of T315i-Positive BCR/ABL
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Tyrosine Kinase Inhibitors in BCR-ABL Positive Acute Lymphoblastic Leukemia
Haematologica
Hematology
Regulation of BCR-Abl-Induced SAP Kinase Activity and Transformation by the SHPTP1 Protein Tyrosine Phosphatase
Oncogene
Cancer Research
Genetics
Molecular Biology
Targeting the SH2-Kinase Interface in BCR-Abl Inhibits Leukemogenesis
Cell
Biochemistry
Genetics
Molecular Biology